Metropolitan Life Insurance Company (MetLife)’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,618
| Closed | -$70.1K | – | 47 |
|
|
2024
Q1 | $70.1K | Sell |
10,618
-1,685
| -14% | -$11.1K | ﹤0.01% | 1242 |
|
|
2023
Q4 | $55.6K | Hold |
12,303
| – | – | ﹤0.01% | 1391 |
|
|
2023
Q3 | $44K | Buy |
12,303
+938
| +8% | +$3.36K | ﹤0.01% | 1479 |
|
|
2023
Q2 | $41.9K | Hold |
11,365
| – | – | ﹤0.01% | 1524 |
|
|
2023
Q1 | $37.6K | Sell |
11,365
-200
| -2% | -$662 | ﹤0.01% | 1544 |
|
|
2022
Q4 | $44.9K | Buy |
11,565
+4,403
| +61% | +$17.1K | ﹤0.01% | 1542 |
|
|
2022
Q3 | $17.4K | Sell |
7,162
-4,242
| -37% | -$10.3K | ﹤0.01% | 2091 |
|
|
2022
Q2 | $22.6K | Buy |
+11,404
| New | +$22.6K | ﹤0.01% | 1991 |
|
|
2020
Q2 | – | Sell |
-26,075
| Closed | -$75.1K | – | 2546 |
|
|
2020
Q1 | $75.1K | Buy |
+26,075
| New | +$75.1K | ﹤0.01% | 2215 |
|
|
2019
Q4 | – | Sell |
-19,125
| Closed | -$85.1K | – | 2536 |
|
|
2019
Q3 | $85.1K | Buy |
+19,125
| New | +$85.1K | ﹤0.01% | 2385 |
|